期刊
CANCER MANAGEMENT AND RESEARCH
卷 14, 期 -, 页码 1421-1429出版社
DOVE MEDICAL PRESS LTD
DOI: 10.2147/CMAR.S351744
关键词
radiotherapy; external beam; computed tomography; 2-deoxy-D-glucose; 2-DG; 2-azido-2-deoxy-D-glucose; 2-AZ-2-DG
类别
资金
- NCI-SBIR [NCI 75N91019C000043, 75N91019C000016]
Recent technological advancements in radiotherapy have improved the efficacy of cancer treatment, leading to increased patient survival and enhanced quality of life. Various new techniques and methods have contributed to more accurate and personalized treatment planning, tumor delineation, and dose estimation, while novel drugs and treatment approaches have also been introduced.
Recent technological advancements have increased the efficacy of radiotherapy, leading to effective management of cancer patients with enhanced patient survival and improved quality of life. Several important developments like multileaf collimator, integration of imaging techniques like positron emission tomography (PET) and computed tomography (CT), involvement of advanced dose calculation algorithms, and delivery techniques have increased tumor dose distribution and decreased normal tissue toxicity. Three-dimensional conformal radiotherapy (3DCRT), intensity-modulated radiotherapy (IMRT), stereotactic radiotherapy, image guided radiotherapy (IGT), and particle therapy have facilitated the planning procedures, accurate tumor delineation, and dose estimation for effective personalized treatment. In this review, we present the technological advancements in various types of EBRT methods and discuss their clinical utility and associated limitations. We also reveal novel approaches of using biocompatible yttrium oxide scintillator-photosensitizer complex (YSM) that can generate X-ray induced cytotoxic reactive oxygen species, facilitating X-ray activated photodynamic therapy (XPDT (external beam) and/or iXPDT (internal X-ray source)) and azido-derivatives of 2-deoxy-D-glucose (2-DG) as agents for site-specific radiation-induced DNA damage.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据